Peak Retirement Planning Inc. Acquires New Shares in Kimberly-Clark Co. (NYSE:KMB)

Peak Retirement Planning Inc. purchased a new stake in Kimberly-Clark Co. (NYSE:KMB - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 6,021 shares of the company's stock, valued at approximately $788,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in shares of Kimberly-Clark by 15.1% in the 4th quarter. Vanguard Group Inc. now owns 35,142,545 shares of the company's stock valued at $4,605,079,000 after purchasing an additional 4,603,787 shares during the period. Norges Bank acquired a new stake in Kimberly-Clark during the fourth quarter worth approximately $582,592,000. First Trust Advisors LP increased its holdings in Kimberly-Clark by 163.1% in the fourth quarter. First Trust Advisors LP now owns 2,142,749 shares of the company's stock worth $280,786,000 after purchasing an additional 1,328,341 shares in the last quarter. Invesco Ltd. lifted its stake in Kimberly-Clark by 21.9% in the fourth quarter. Invesco Ltd. now owns 5,653,751 shares of the company's stock valued at $740,868,000 after buying an additional 1,015,141 shares during the period. Finally, Raymond James Financial Inc. bought a new position in shares of Kimberly-Clark during the 4th quarter worth approximately $127,436,000. Institutional investors and hedge funds own 76.29% of the company's stock.

Kimberly-Clark Stock Up 1.0%

Shares of KMB stock traded up $1.35 during trading hours on Tuesday, reaching $142.90. The company had a trading volume of 2,594,113 shares, compared to its average volume of 2,186,334. The company has a market cap of $47.42 billion, a price-to-earnings ratio of 18.93, a price-to-earnings-growth ratio of 4.46 and a beta of 0.35. The company has a debt-to-equity ratio of 7.05, a current ratio of 0.80 and a quick ratio of 0.54. Kimberly-Clark Co. has a 12 month low of $124.10 and a 12 month high of $150.45. The business has a fifty day simple moving average of $137.23 and a 200-day simple moving average of $135.07.

Kimberly-Clark (NYSE:KMB - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.89 by $0.04. The business had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.90 billion. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%. During the same period in the prior year, the firm posted $2.01 EPS. On average, research analysts expect that Kimberly-Clark Co. will post 7.5 earnings per share for the current fiscal year.

Kimberly-Clark Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 2nd. Investors of record on Friday, June 6th will be issued a dividend of $1.26 per share. This represents a $5.04 annualized dividend and a yield of 3.53%. The ex-dividend date is Friday, June 6th. Kimberly-Clark's dividend payout ratio (DPR) is presently 68.66%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on KMB shares. UBS Group boosted their target price on shares of Kimberly-Clark from $134.00 to $146.00 and gave the company a "neutral" rating in a research report on Thursday, April 17th. Royal Bank of Canada dropped their price objective on shares of Kimberly-Clark from $165.00 to $162.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Piper Sandler reduced their target price on Kimberly-Clark from $158.00 to $156.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. JPMorgan Chase & Co. upped their price target on Kimberly-Clark from $124.00 to $131.00 and gave the stock an "underweight" rating in a research note on Friday, April 11th. Finally, Wall Street Zen lowered Kimberly-Clark from a "buy" rating to a "hold" rating in a report on Thursday, April 24th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, Kimberly-Clark currently has a consensus rating of "Hold" and a consensus price target of $145.08.

Insiders Place Their Bets

In other news, insider Katy Chen sold 740 shares of the stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $129.70, for a total transaction of $95,978.00. Following the completion of the transaction, the insider now directly owns 3,997 shares of the company's stock, valued at $518,410.90. This represents a 15.62% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Andrew Drexler sold 10,838 shares of the company's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $141.00, for a total value of $1,528,158.00. Following the transaction, the vice president now directly owns 7,720 shares in the company, valued at $1,088,520. This represents a 58.40% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,372 shares of company stock valued at $1,858,684. Corporate insiders own 0.64% of the company's stock.

Kimberly-Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.